Try Ask OE! Our NEW Advanced AI Enabled Search
Dive into the Largest Database of
Musculoskeletal Evidence
ACE Reports.
Make a selection below to explore our full database of 4 results matching: "J Maddox"
ACE Reports
(4 Reports)
ACE Reports
Our Al driven High Impact metric predicts an article's future number of citations by considering the content of the article.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Open Advanced Search
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Spine
24-month chronic low back pain relief from an accessible 8-week in-home behavioral VR program
Pain Med. 2023 01-Oct;():. 10.1093/pm/pnad070
24-month chronic low back pain relief from an accessible 8-week in-home behavioral VR program
Pain Med. 2023 01-Oct;():. 10.1093/pm/pnad070
Trauma
Romosozumab has no impact on radiographic or clinical outcomes following hip fracture ORIF
J Bone Joint Surg Am. 2020 ;():. 10.2106/JBJS.19.00790
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Romosozumab has no impact on radiographic or clinical outcomes following hip fracture ORIF
J Bone Joint Surg Am. 2020 ;():. 10.2106/JBJS.19.00790
General Orthopaedics
Lower incidence of vertebral fracture with romosozumab vs placebo for osteoporosis
N Engl J Med. 2016 Oct 20;375(16):1532-1543
Lower incidence of vertebral fracture with romosozumab vs placebo for osteoporosis
N Engl J Med. 2016 Oct 20;375(16):1532-1543
Metabolic Disorders
WCO-IOF 2016: Greater BMD increase after 1 year of romosozumab vesus teripratide
WCO-IOF 2016: Greater BMD increase after 1 year of romosozumab vesus teripratide